Novel trends in celiac disease

被引:21
作者
Matthias, Torsten [1 ]
Neidhoefer, Sandra [1 ]
Pfeiffer, Sascha [2 ]
Prager, Kai [2 ]
Reuter, Sandra [1 ]
Gershwin, M. Eric [3 ]
机构
[1] AESKU KIPP Inst, D-55234 Wendelsheim, Germany
[2] AESKU Diagnost GmbH & Co KG, Wendelsheim, Germany
[3] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
关键词
celiac disease; tissue transglutaminase; celiac neo-epitope; gluten; diagnostic marker; GLUTEN-FREE DIET; TISSUE TRANSGLUTAMINASE; GLIADIN PEPTIDES; DIAGNOSTIC-ACCURACY; STRUCTURAL BASIS; PREVALENCE; TESTS; ANTIBODIES; SEROLOGY; GENETICS;
D O I
10.1038/cmi.2010.68
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Celiac disease (CD) is one of the most common food intolerances in developed world. It affects genetically susceptible individuals and has severe consequences if it remains undiagnosed. A disease known for more than a century, it is still the focus for experts from various fields of research and development. Geneticists, pathologists, immunologists, food engineers and dieticians share their knowledge and expertise to improve the conditions of CD patients. With new insights in the pathomechanism of gluten processing and antigen presentation in CD, it was possible to improve the diagnostic antigen mimicking the primary epitope in CD. These celiac neo-epitopes are comprised of a complex of gliadin peptides crosslinked with transglutaminase (tTg). They are an early diagnostic marker for CD which occurs up to 6 months earlier than classical markers known to miss a certain amount of CD patients. Cellular & Molecular Immunology (2011) 8, 121-125; doi:10.1038/cmi.2010.68; published online 31 January 2011
引用
收藏
页码:121 / 125
页数:5
相关论文
共 68 条
[21]   Characteristics of adult celiac disease in the USA: Results of a national survey [J].
Green, PHR ;
Stavropoulos, SN ;
Panagi, SG ;
Goldstein, SL ;
McMahon, DJ ;
Absan, H ;
Neugut, AI .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (01) :126-131
[22]   Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease - A population-based screening study with 2 years' follow-up [J].
Hansen, Dorte ;
Brock-Jacobsen, Bendt ;
Lund, Elisabeth ;
Bjorn, Christina ;
Hansen, Lars P. ;
Nielsen, Christian ;
Fenger, Claus ;
Lillevang, Soren T. ;
Husby, Steffen .
DIABETES CARE, 2006, 29 (11) :2452-2456
[23]   Intestinal digestive resistance of immunodominant gliadin peptides [J].
Hausch, F ;
Shan, L ;
Santiago, NA ;
Gray, GM ;
Khosla, C .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 283 (04) :G996-G1003
[24]   Extraintestinal manifestations of celiac disease [J].
Hernandez L. ;
Green P.H. .
Current Gastroenterology Reports, 2006, 8 (5) :383-389
[25]   A prospective study of the incidence of childhood celiac disease [J].
Hoffenberg, EJ ;
MacKenzie, T ;
Barriga, KJ ;
Eisenbarth, GS ;
Bao, F ;
Haas, JE ;
Erlich, H ;
Bugawan, TL ;
Sokol, RJ ;
Taki, I ;
Norris, JM ;
Rewers, M .
JOURNAL OF PEDIATRICS, 2003, 143 (03) :308-314
[26]   Definitions of Celiac disease - Statement of an expert group from the German society for Celiac disease [J].
Holtmeier, W ;
Henker, J ;
Riecken, EO ;
Zimmer, KP .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2005, 43 (08) :751-754
[27]   Epidemiology and estimated population burden of selected autoimmune diseases in the United States [J].
Jacobson, DL ;
Gange, SJ ;
Rose, NR ;
Graham, NMH .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (03) :223-243
[28]   HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer:: Results from the European genetics cluster on celiac disease [J].
Karell, K ;
Louka, AS ;
Moodie, SJ ;
Ascher, H ;
Clot, F ;
Greco, L ;
Ciclitira, PJ ;
Sollid, LM ;
Partanen, J .
HUMAN IMMUNOLOGY, 2003, 64 (04) :469-477
[29]   Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease [J].
Kim, CY ;
Quarsten, H ;
Bergseng, E ;
Khosla, C ;
Sollid, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) :4175-4179
[30]   Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests) [J].
Lewis, N. R. ;
Scott, B. B. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (01) :47-54